Literature DB >> 21073766

Chikungunya epidemic-related mortality.

S P Manimunda1, D Mavalankar, T Bandyopadhyay, A P Sugunan.   

Abstract

Port Blair, the capital city of the Union Territory of Andaman and Nicobar Islands in the republic of India, witnessed an outbreak of chikungunya (CHIK) fever in 2006. Although no deaths attributable to CHIK fever were registered, thousands of people were affected. In view of evidence from other parts of the world indicating that CHIK fever does cause death we studied the mortality trend in Port Blair from 2002 to 2008 in order to verify if there was increased mortality during the CHIK fever epidemic. The expected number of monthly deaths in 2006 was calculated by multiplying the average monthly mortality rate from 2002 to 2008 (with the exception of 2006) with the monthly population in 2006. The results indicated that there was a significant increase in expected deaths during some months of 2006, which coincided with the peak in the CHIK fever epidemic in Port Blair.

Entities:  

Mesh:

Year:  2010        PMID: 21073766     DOI: 10.1017/S0950268810002542

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

1.  Excess deaths associated with the 2014 chikungunya epidemic in Jamaica.

Authors:  André Ricardo Ribas Freitas; Patrick Gérardin; Luiza Kassar; Maria Rita Donalisio
Journal:  Pathog Glob Health       Date:  2019-02-04       Impact factor: 2.894

Review 2.  Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases.

Authors:  Scott C Weaver; Caroline Charlier; Nikos Vasilakis; Marc Lecuit
Journal:  Annu Rev Med       Date:  2017-08-28       Impact factor: 13.739

Review 3.  The Range of Neurological Complications in Chikungunya Fever.

Authors:  T Cerny; M Schwarz; U Schwarz; J Lemant; P Gérardin; E Keller
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

4.  Chikungunya virus-induced autophagy delays caspase-dependent cell death.

Authors:  Pierre-Emmanuel Joubert; Scott W Werneke; Claire de la Calle; Florence Guivel-Benhassine; Alessandra Giodini; Lucie Peduto; Beth Levine; Olivier Schwartz; Deborah J Lenschow; Matthew L Albert
Journal:  J Exp Med       Date:  2012-04-16       Impact factor: 14.307

5.  Chikungunya virus infection.

Authors:  Fabrice Simon; Emilie Javelle; Manuela Oliver; Isabelle Leparc-Goffart; Catherine Marimoutou
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

Review 6.  Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia.

Authors:  Laurence Dupuis-Maguiraga; Marion Noret; Sonia Brun; Roger Le Grand; Gabriel Gras; Pierre Roques
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

7.  Excess mortality in Guadeloupe and Martinique, islands of the French West Indies, during the chikungunya epidemic of 2014.

Authors:  A R R Freitas; P M Alarcón-Elbal; M R Donalisio
Journal:  Epidemiol Infect       Date:  2018-08-28       Impact factor: 4.434

8.  Distinguishing patients with laboratory-confirmed chikungunya from dengue and other acute febrile illnesses, Puerto Rico, 2012-2015.

Authors:  Luisa I Alvarado; Olga D Lorenzi; Brenda C Torres-Velásquez; Tyler M Sharp; Luzeida Vargas; Jorge L Muñoz-Jordán; Elizabeth A Hunsperger; Janice Pérez-Padilla; Aidsa Rivera; Gladys E González-Zeno; Renee L Galloway; Mindy Glass Elrod; Demetrius L Mathis; M Steven Oberste; W Allan Nix; Elizabeth Henderson; Jennifer McQuiston; Joseph Singleton; Cecilia Kato; Carlos García-Gubern; William Santiago-Rivera; Robert Muns-Sosa; Juan D Ortiz-Rivera; Gerson Jiménez; Vanessa Rivera-Amill; Doris A Andújar-Pérez; Kalanthe Horiuchi; Kay M Tomashek
Journal:  PLoS Negl Trop Dis       Date:  2019-07-22

Review 9.  Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy.

Authors:  Simon-Djamel Thiberville; Nanikaly Moyen; Laurence Dupuis-Maguiraga; Antoine Nougairede; Ernest A Gould; Pierre Roques; Xavier de Lamballerie
Journal:  Antiviral Res       Date:  2013-06-28       Impact factor: 5.970

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.